- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Irinotecan – November 2016
Irinotecan (nanoliposomal): Injection concentrate for I.V. infusion 43 mg (as sucrosofate) in 10 mL; Onivyde®
Last updated
17 March 2017